insights_auto
Outlook: 71.2% bullish·1.9% bearish
Go to analysischevron_right
ABBV:NYSE
AbbVie Common Stock
$266.69
arrow_upward
+0.36%(+0.95) 1D
$266.69
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:03:51 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV...
Open
$267.74
High
$268.86
Low
$260.62
Mkt. cap
466.06B
Avg. vol.
4.24M
Volume
4.50M
Dividend
2.59%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
75.43
52-wk high
$269.39
52-wk low
$190.75
EPS
$3.54
Beta
0.23
Shares outstanding
1.77B
No. of employees
57K
Open
$267.74
High
$268.86
Low
$260.62
Mkt. cap
466.06B
Avg. vol.
4.24M
Volume
4.50M
Dividend
2.59%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
75.43
52-wk high
$269.39
52-wk low
$190.75
EPS
$3.54
Beta
0.23
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
GuruFocus
·
4 hours ago
AbbVie Stocks Edge Higher as Lymphoma Trial Cuts Progression Risk 51%
The Motley Fool
·
5 hours ago
HSBC Thinks AbbVie Can Climb to $315. Here's the Bull Case in Plain English.
Benzinga
·
8 hours ago
9 Of 11 Sectors Rise In Tuesday Trading As Defensives Lead
Zacks
·
8 hours ago
AbbVie's Epcoritamab Combo Shows PFS Benefit in Frontline DLBCL
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com